Botor, M.; Auguściak-Duma, A.; Lesiak, M.; Sieroń, Ł.; Dziedzic-Kowalska, A.; Witecka, J.; Asman, M.; Madetko-Talowska, A.; Bik-Multanowski, M.; Galicka, A.;
et al. Analysis of miRNAs in Osteogenesis imperfecta Caused by Mutations in COL1A1 and COL1A2: Insights into Molecular Mechanisms and Potential Therapeutic Targets. Pharmaceuticals 2023, 16, 1414.
https://doi.org/10.3390/ph16101414
AMA Style
Botor M, Auguściak-Duma A, Lesiak M, Sieroń Ł, Dziedzic-Kowalska A, Witecka J, Asman M, Madetko-Talowska A, Bik-Multanowski M, Galicka A,
et al. Analysis of miRNAs in Osteogenesis imperfecta Caused by Mutations in COL1A1 and COL1A2: Insights into Molecular Mechanisms and Potential Therapeutic Targets. Pharmaceuticals. 2023; 16(10):1414.
https://doi.org/10.3390/ph16101414
Chicago/Turabian Style
Botor, Malwina, Aleksandra Auguściak-Duma, Marta Lesiak, Łukasz Sieroń, Agata Dziedzic-Kowalska, Joanna Witecka, Marek Asman, Anna Madetko-Talowska, Mirosław Bik-Multanowski, Anna Galicka,
and et al. 2023. "Analysis of miRNAs in Osteogenesis imperfecta Caused by Mutations in COL1A1 and COL1A2: Insights into Molecular Mechanisms and Potential Therapeutic Targets" Pharmaceuticals 16, no. 10: 1414.
https://doi.org/10.3390/ph16101414
APA Style
Botor, M., Auguściak-Duma, A., Lesiak, M., Sieroń, Ł., Dziedzic-Kowalska, A., Witecka, J., Asman, M., Madetko-Talowska, A., Bik-Multanowski, M., Galicka, A., Sieroń, A. L., & Gawron, K.
(2023). Analysis of miRNAs in Osteogenesis imperfecta Caused by Mutations in COL1A1 and COL1A2: Insights into Molecular Mechanisms and Potential Therapeutic Targets. Pharmaceuticals, 16(10), 1414.
https://doi.org/10.3390/ph16101414